Literature DB >> 11751756

The ontogeny of B cells in the thymus of normal, CD3 epsilon knockout (KO), RAG-2 KO and IL-7 transgenic mice.

Rhodri Ceredig1.   

Abstract

The ontogeny of thymic B cells was determined by three-color flow cytometry and the presence or absence of B cell progenitors confirmed by cell culture experiments. In the thymus of young normal mice, CD117(+), B220(low) pro- and pre-B cells are present but disappear with age. B220(low), CD5(+), B-1 B cells are present in the thymus of older animals following the appearance of similar cells in the peritoneal cavity and blood. In CD3 epsilon gene-deleted mice, the phenotypic progression and number of thymic B cells remains unaltered, showing that blocking T cell development does not automatically result in an increase of thymic B lymphopoiesis. Pro-B cells in RAG-2 knockout mice are found in the fetal and neonatal blood, spleen and thymus, but with increasing age are only found in the bone marrow. B lymphopoiesis in adult IL-7 transgenic mice is dramatically altered with CD117(+) pro- and pre-B cells present in spleen, lymph node and blood. In the thymus of adult IL-7 transgenic mice, the fraction of CD117(+) thymic B cells is significantly increased. These results show that in the steady state, the phenotype of thymic B cells is critically dependent on both mouse age and the phenotype of circulating B cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11751756     DOI: 10.1093/intimm/14.1.87

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  11 in total

1.  Polyreactive antigen-binding B (PAB-) cells are widely distributed and the PAB population consists of both B-1+ and B-1- phenotypes.

Authors:  Z-H Zhou; A L Notkins
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

Review 2.  The development and function of thymic B cells.

Authors:  Jason Perera; Haochu Huang
Journal:  Cell Mol Life Sci       Date:  2015-04-03       Impact factor: 9.261

3.  Antibody repertoire development in fetal and neonatal piglets. XI. The thymic B-cell repertoire develops independently from that in blood and mesenteric lymph nodes.

Authors:  Jeremy McAleer; Patrick Weber; Jishan Sun; John E Butler
Journal:  Immunology       Date:  2005-02       Impact factor: 7.397

4.  B cells and B cell products-helping to restore cellular immunity?

Authors:  Marilia Cascalho; Jeffrey L Platt
Journal:  Transfus Med Hemother       Date:  2006       Impact factor: 3.747

5.  Regulation of lymphocyte development by cell-type-specific interpretation of Notch signals.

Authors:  Lei Nie; S Scott Perry; Ying Zhao; Jiaxue Huang; Paul W Kincade; Michael A Farrar; Xiao-Hong Sun
Journal:  Mol Cell Biol       Date:  2008-01-14       Impact factor: 4.272

6.  High levels of IL-7 cause dysregulation of thymocyte development.

Authors:  Nahed El-Kassar; Francis A Flomerfelt; Baishakhi Choudhury; Lee A Hugar; Kevin S Chua; Veena Kapoor; Philip J Lucas; Ronald E Gress
Journal:  Int Immunol       Date:  2012-08-16       Impact factor: 4.823

7.  Critical role for thymic CD19+CD5+CD1dhiIL-10+ regulatory B cells in immune homeostasis.

Authors:  Chen Xing; Ning Ma; He Xiao; Xiaoqian Wang; Mingke Zheng; Gencheng Han; Guojiang Chen; Chunmei Hou; Beifen Shen; Yan Li; Renxi Wang
Journal:  J Leukoc Biol       Date:  2014-12-16       Impact factor: 4.962

8.  Autoreactive thymic B cells are efficient antigen-presenting cells of cognate self-antigens for T cell negative selection.

Authors:  Jason Perera; Liping Meng; Fanyong Meng; Haochu Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-30       Impact factor: 11.205

Review 9.  Osteoclastic differentiation and function regulated by old and new pathways.

Authors:  Harry C Blair; Mone Zaidi
Journal:  Rev Endocr Metab Disord       Date:  2006-06       Impact factor: 9.306

10.  Thymic B cell development is controlled by the B potential of progenitors via both hematopoietic-intrinsic and thymic microenvironment-intrinsic regulatory mechanisms.

Authors:  Shiyun Xiao; Wen Zhang; Nancy R Manley
Journal:  PLoS One       Date:  2018-02-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.